Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$9,403
+$6,348 QoQ
Shares Held
60
+100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,542
of 1,603 holders
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Buck Wealth Strategies, LLC holds $30,970,176 across 15 Drug Manufacturers - General names. NVS ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
113,226 | $14,549,541 | |
| 2 | AMGN |
Amgen Inc
|
39,968 | $14,473,212 | |
| 3 | LLY |
ELI LILLY & Co
|
660 | $791,623 | |
| 4 | JNJ |
Johnson & Johnson
|
1,994 | $506,416 | |
| 5 | ABBV |
AbbVie Inc.
|
1,587 | $399,352 | |
| 6 | PFE |
Pfizer Inc
|
3,426 | $82,498 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,107 | $63,785 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
429 | $54,199 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,403 | 60 | Shares | Sole | 2026-07-30 | |
| 2023-09-30 | $3,055 | 30 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $3,027 | 30 | Shares | Sole | 2023-11-06 | |
| 2023-03-31 | $2,760 | 30 | Shares | Sole | 2023-11-06 | |
| No filing history on record for this holder in this stock. | ||||||